Beneficial Effects of Long-Term Administration of an Oral Formulation of Angiotensin-(1–7) in Infarcted Rats

Figure 3

Effects of HPβCD/Ang-(1–7) on the variation of the velocity and displacement in rats after (a and b) 15 days; (c and d) 30 days, and (e and f) 50 days of treatment. ^∗𝑃<0.05 versus sham; ^†𝑃<0.05 versus MI; ^‡𝑃<0.01 versus MI (one-way ANOVA followed by the Newman-Keuls posttest).